secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ovid Therapeutics Inc. (OVID)
CIK:        0001636651
Form:       8-K
Filed at:   2021-08-18T23:59:59+00:00
Accession:  0001564590-21-044971
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ovid posts August 2021 corporate overview; no specific financial or operational updates provided in filing
--------------------------------------------------------------------------------

- Company posted corporate presentation to website but full content not included in filing text.
- No new financial guidance, clinical trial results, or business developments disclosed.
- Presentation likely covers pipeline, strategy, and forward-looking statements.
- Filing is a routine disclosure of a corporate overview; no specific numbers available.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636651/000156459021044971/0001564590-21-044971-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636651/000156459021044971/ovid-8k_20210818.htm
  HTML page:      https://secwatch.observer/filing/0001564590-21-044971

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer